Assignee
LAURUS LABS LTD
IN·34 granted patents·6 pending applications·6 citations·filing 2015–2022
Top patents by PatentIndex Score
40 records- 0179US10428053B2Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereofLAURUS LABS LTD·Filed 2016·Granted Oct 1, 2019·3 cites·20 claims
- 0279US9957234B2Polymorphs of Ivacaftor, process for its preparation and pharmaceutical composition thereofLAURUS LABS LTD·Filed 2015·Granted May 1, 2018·2 cites·52 claims
- 0372US10836753B2Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereofLAURUS LABS LTD·Filed 2019·Granted Nov 17, 2020·0 cites·3 claims
- 0471US10815202B2Process for the preparation of ivacaftorLAURUS LABS LTD·Filed 2019·Granted Oct 27, 2020·0 cites·13 claims
- 0570US11414386B2Process for the preparation of ivacaftor and its intermediatesLAURUS LABS LTD·Filed 2020·Granted Aug 16, 2022·0 cites·41 claims
- 0668US12071418B2Processes for preparation of dapagliflozin or its solvates or co-crystals thereofLAURUS LABS LTD·Filed 2022·Granted Aug 27, 2024·0 cites·23 claims
- 0767US11040961B2Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereofLAURUS LABS LTD·Filed 2019·Granted Jun 22, 2021·0 cites·8 claims
- 0867US10654872B1Polymorphs of dolutegravir and salts thereofLAURUS LABS LTD·Filed 2020·Granted May 19, 2020·0 cites·6 claims
- 0967US10647729B1Polymorphs of dolutegravir and salts thereofLAURUS LABS LTD·Filed 2020·Granted May 12, 2020·0 cites·10 claims
- 1065US11427570B2Process for the preparation of pazopanib or a pharmaceutically acceptable salt thereofLAURUS LABS LTD·Filed 2020·Granted Aug 30, 2022·0 cites·38 claims
- 1165US11299477B2Process for the preparation of Pazopanib or a pharmaceutically acceptable salt thereofLAURUS LABS LTD·Filed 2020·Granted Apr 12, 2022·0 cites·14 claims
- 1264US10800809B2Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereofLAURUS LABS LTD·Filed 2019·Granted Oct 13, 2020·0 cites·13 claims
- 1363US11345685B2Process and crystalline forms of lumacaftorLAURUS LABS LTD·Filed 2020·Granted May 31, 2022·0 cites·8 claims
- 1463US10738038B2Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereofLAURUS LABS LTD·Filed 2019·Granted Aug 11, 2020·0 cites·7 claims
- 1563US10597404B2Polymorphs of dolutegravir and salts thereofLAURUS LABS LTD·Filed 2016·Granted Mar 24, 2020·0 cites·17 claims
- 1662US11345684B2Process and crystalline forms of LumacaftorLAURUS LABS LTD·Filed 2020·Granted May 31, 2022·0 cites·8 claims
- 1762US10626091B2Process for the preparation of enzalutamideLAURUS LABS LTD·Filed 2018·Granted Apr 21, 2020·0 cites·13 claims
- 1861US10844048B2Process and crystalline forms of lumacaftorLAURUS LABS LTD·Filed 2018·Granted Nov 24, 2020·0 cites·22 claims
- 1961US10544157B2Process for preparation of DarunavirLAURUS LABS LTD·Filed 2019·Granted Jan 28, 2020·0 cites·6 claims
- 2058US11634431B2Process for purification of protected polycyclic carbamoylpyridone derivativesLAURUS LABS LTD·Filed 2019·Granted Apr 25, 2023·1 cites·17 claims
- 2158US10301321B2Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereofLAURUS LABS LTD·Filed 2017·Granted May 28, 2019·0 cites·21 claims
- 2258US2023348391A1An improved process for the preparation of trigonelline or pharmaceutically acceptable salts thereofLAURUS LABS LTD·Filed 2021·Application pending·0 cites
- 2357US12065426B2Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the sameLAURUS LABS LTD·Filed 2019·Granted Aug 20, 2024·0 cites·12 claims
- 2455US11318116B2Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereofLAURUS LABS LTD·Filed 2020·Granted May 3, 2022·0 cites·14 claims
- 2555US10857132B2Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereofLAURUS LABS LTD·Filed 2017·Granted Dec 8, 2020·0 cites·23 claims
- 2652US2024309017A1Processes for purification of bictegravir intermediatesLAURUS LABS LTD·Filed 2021·Application pending·0 cites
- 2751US2025057783A1Oral films of antipruritic drugsLAURUS LABS LTD·Filed 2022·Application pending·0 cites
- 2848US11427555B2Processes for preparation of dapagliflozin or its solvates or co-crystals thereofLAURUS LABS LTD·Filed 2017·Granted Aug 30, 2022·0 cites·37 claims
- 2948US2024189299A1Oral film of cftr modulator(s)LAURUS LABS LTD·Filed 2022·Application pending·0 cites
- 3047US11434196B2Process for preparation of 2-Amino-5-hydroxy propiophenoneLAURUS LABS LTD·Filed 2020·Granted Sep 6, 2022·0 cites·31 claims
- 3145US10131636B2Process for the preparation of EnzalutamideLAURUS LABS LTD·Filed 2015·Granted Nov 20, 2018·0 cites·18 claims
- 3245US2023157949A1Oral film of hiv drugsLAURUS LABS LTD·Filed 2021·Application pending·0 cites
- 3341US9850285B2Process for preparing eptifibatideLAURUS LABS LTD·Filed 2015·Granted Dec 26, 2017·0 cites·7 claims
- 3440US12577236B2Processes for preparation of TezacaftorLAURUS LABS LTD·Filed 2021·Granted Mar 17, 2026·0 cites·20 claims
- 3540US11066368B2Process for the preparation and particle size reduction of pirfenidoneLAURUS LABS LTD·Filed 2018·Granted Jul 20, 2021·0 cites·30 claims
- 3640US2019216738A1Pirfenidone-containing tablet and capsule formulationLAURUS LABS LTD·Filed 2018·Application pending·0 cites
- 3738US11053220B2Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) anilineLAURUS LABS LTD·Filed 2018·Granted Jul 6, 2021·0 cites·24 claims
- 3835US11046676B2Process for preparation of empagliflozin or its co-crystals, solvates and their polymorphs thereofLAURUS LABS LTD·Filed 2018·Granted Jun 29, 2021·0 cites·49 claims
- 3933US10669264B2Process for the preparation of macitentanLAURUS LABS LTD·Filed 2016·Granted Jun 2, 2020·0 cites·11 claims
- 4031US12486286B2Process and polymorphic forms of bictegravir and its pharmaceutically acceptable salts or co-crystals thereofLAURUS LABS LTD·Filed 2020·Granted Dec 2, 2025·0 cites·27 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →